Terry-Ann Burrell - Jun 30, 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
CFO
Signature
/s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jun 30, 2021
Transactions value $
-$3,249,600
Form type
4
Date filed
7/2/2021, 06:01 PM
Previous filing
Jun 30, 2021
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $410K +30K +120.92% $13.68 54.8K Jun 30, 2021 Direct F1
transaction BEAM Common Stock Sale -$1.76M -15K -27.37% $117.00 39.8K Jun 30, 2021 Direct F2
transaction BEAM Common Stock Sale -$1.91M -15K -37.68% $127.00 24.8K Jun 30, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -30K -9.59% $0.00 283K Jun 30, 2021 Common Stock 30K $13.68 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercise reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 The option vests as to 25% on the first anniversary of the of the vesting commencement date, August 20, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.